EVR NAT (Everolimus 10 mg)
Pill with imprint EVR NAT is White, Elliptical/Oval and has been identified as Everolimus 10 mg. It is supplied by Breckenridge Pharmaceutical, Inc.
Everolimus is used in the treatment of breast cancer; neuroendocrine carcinoma; organ transplant, rejection prophylaxis; renal angiomyolipoma; pancreatic cancer and belongs to the drug classes mTOR inhibitors, selective immunosuppressants. There is positive evidence of human fetal risk during pregnancy. Everolimus 10 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for EVR NAT
Everolimus
- Imprint
- EVR NAT
- Strength
- 10 mg
- Color
- White
- Shape
- Elliptical/Oval
- Availability
- Prescription only
- Drug Class
- MTOR inhibitors, Selective immunosuppressants
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Breckenridge Pharmaceutical, Inc.
- Manufacturer
- Natco Pharma Ltd.
- National Drug Code (NDC)
- 51991-0824
More about everolimus
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (24)
- Drug images
- Pricing & coupons
- En español
- Drug class: mTOR inhibitors
Patient resources
- Drug Information
- Everolimus (Advanced Reading)
- Everolimus Tablets (Afinitor)
- Everolimus Tablets (Zortress)
- Everolimus Tablets For Oral Suspension
- Other brands
- Afinitor, Zortress, Afinitor Disperz
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.